Ahmed Khattab

MD
Medical Oncology and Hematology

About Ahmed Khattab

Biography:

Dr. Khattab is a board-certified medical oncologist and hematologist at Roswell Park Comprehensive Cancer Center. Originally from Toronto, Canada and trained in Pittsburgh, PA, he approaches patient care with genuine compassion, striving to understand each individual's unique journey. His dedication to providing comprehensive and evidence-based treatments stems from a commitment of continuous learning and staying abreast of the latest advancements in oncology.

Positions

Roswell Park Care Network
  • Assistant Professor of Oncology
  • Department of Medicine, Hematology and Oncology
  • Roswell Park Hematology Oncology Southtowns

State University of New York at Buffalo

  • Assistant Professor of Medicine

Background

Education and Training:

  • 2017 - MD - Ross University School of Medicine, St. Clair, MI
  • 2012 - BA - Public Health and Safety, Ryerson University, Toronto, Canada

Residency:

  • 2017-2020 - Internal Medicine, Allegheny Health Network, Drexel University College of Medicine, Pittsburgh, PA

Fellowship:

  • 2020-2023 - Hematology and Oncology, Allegheny Health Network, Drexel University College of Medicine, Pittsburgh, PA

Board Certification:

  • 2023 - American Board of Internal Medicine, Medical Oncology
  • 2023 - American Board of Internal Medicine, Hematology
  • 2020 - American Board of Internal Medicine, Internal Medicine

Professional Memberships:

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American College of Physicians
  • American Medical Association
  • Pennsylvania Society of Oncology and Hematology

Honors & Awards:

  • Canadian Founder Scholarship
  • 2019, 2021 - 1st Place Abstract Competition - The Pennsylvania Society of Oncology and Hematology (PSOH Annual Meeting)

Publications

Full Publications list on PubMed

Khattab A, Garciafigueroa Y, Phillips B, Patruni S, Khatoon N, Miller S, Giannoukakis N, Monga D. Significant neutrophil accumulation, IL-18 deposition, and active inflammasome in tumor regions of human pancreatic ductal adenocarcinoma. Journal of Clinical Oncology 2019 37:15_suppl, e15754-e15754.

Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. J Gastrointest Oncol. 2019 Oct;10(5):918-927. doi: 10.21037/jgo.2019.07.02. PMID: 31602330; PMCID: PMC6776797.

Khattab, A., Patruni, S., Patrus, G., Samhouri, Y., Fazal, S., & Lister, J. (2023). Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal Of Hematology, 12(2), 138-144.

Khattab A. Park S, Patruni S, Daboul N, Monga D. Case Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen. (2019). Mathews J Gastroenterol Hepatol. 4(1): 13.

Patruni, S., Khattab, A., Abel, S., Hasan, S., Rizwan, S., Finley, G.G., Monga, D.K., Verma, V., & Wegner, R.E. (2019). A comparative analysis of survival in patients with non-small cell lung cancer with brain metastases receiving intracranial radiation with and without immunotherapy. Journal of Clinical Oncology. 37:15_suppl, 9025-9025.